Your browser doesn't support javascript.
loading
Glucagon like peptide-1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population-based cohort study.
Pradhan, Richeek; Yu, Oriana H Y; Platt, Robert W; Azoulay, Laurent.
  • Pradhan R; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
  • Yu OHY; Centre for Clinical Epidemiology, Jewish General Hospital, Lady Davis Institute, Montreal, Quebec, Canada.
  • Platt RW; Centre for Clinical Epidemiology, Jewish General Hospital, Lady Davis Institute, Montreal, Quebec, Canada.
  • Azoulay L; Division of Endocrinology, Jewish General Hospital, Montreal, Quebec, Canada.
Diabet Med ; 41(4): e15248, 2024 Apr.
Article en En | MEDLINE | ID: mdl-37876318

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Melanoma Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Melanoma Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article